22.418 articles found

Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.

Olanow CW, Obeso JA, Stocchi F.

Nat Clin Pract Neurol · 2006-07-01

DOI: 10.1038/ncpneuro0222PMID: 16932589

Dementia with lewy bodies: therapeutic opportunities and pitfalls.

Henriksen AL, St Dennis C, Setter SM, Tran JT.

Consult Pharm · 2006-07-01

DOI: 10.4140/tcp.n.2006.563PMID: 16934009

[Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease].

Krivoborodov GG, Gekht AB, Korshunova ES.

Urologiia · 2006-07-01

PMID: 17058670

[Levodopa for Parkinson's disease: What have we learned?].

Juri C C, Chaná C P.

Rev Med Chil · 2006-07-01

DOI: 10.4067/s0034-98872006000700014PMID: 17130974

New drug treatment for Parkinson's disease.

Check source for author details

FDA Consum · 2006-07-01

PMID: 17245831

METHOD AND COMPOSITION TO INDIVIDUALIZE LEVODOPA/CARBIDOPA THERAPY USING A BREATH TEST

MODAK Anil S., KUROGI Yasuhisa.

· 2006-06-30

Method and composition to individualize Levodopa/Carbidopa therapy using a breath test

MODAK ANIL S, KUROGI YASUHISA.

· 2006-06-30

Vesicular monoamine transporter gene therapy in Parkinson's disease

KANG UN JUNG.

· 2006-06-29

PHARMACEUTICAL FOR TREATMENT OF PARKINSON¿S DISEASE

HIGASHIDA Haruhiro, YOKOYAMA Shigeru, KIN Taku, OHKUMA Shoji, SHIMIZU Nobuaki, HIRAI Hirokazu, MURAMATSU Shinichi.

· 2006-06-28

Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.

Leroi I, Collins D, Marsh L.

J Neurol Sci · 2006-06-27

DOI: 10.1016/j.jns.2006.05.021PMID: 16806271

USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE

WOLF Hans Uwe, WILHELM Christoph.

· 2006-06-26

USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE

WOLF HANS UWE, WILHELM CHRISTOPH.

· 2006-06-26